Skip to main content

Secukinumab Effect on CV Risks in PsA, axSpA: Dr. Sheila Reyes

Dr. Reyes discusses abstract #1835 presented at the ACR21 annual meeting.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.